SCHEMBL6719052

SCHEMBL6719052

Cc1cccc(NC(=O)C(c2ccccc2)N(C(=O)O)C(C)(C)C)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
MEN1 O00255 6/20 0.46
KMT2A Q03164 6/20 0.46
HPGD P15428 1/20 0.46
HSD17B10 Q99714 1/20 0.46
TP53 P04637 1/20 0.46
GAA P10253 1/20 0.45
EGFR P00533 1/20 0.43
MMP1 P03956 1/20 0.43
MMP2 P08253 1/20 0.43
MMP9 P14780 1/20 0.43
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43
KCNK3 O14649 1/20 0.43
POLB P06746 1/20 0.43
KCNK9 Q9NPC2 1/20 0.43
LMNA P02545 1/20 0.43
MAPT P10636 1/20 0.43
ALOX12 P18054 1/20 0.43
HTT P42858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6723623 0.88 POLB (0.51) ALDH1A1MEN1KMT2AHSD17B10GAA
SCHEMBL6714344 0.86 ALDH1A1 (0.56) ALDH1A1MEN1KMT2AHPGDTP53
SCHEMBL6716854 0.86 ALDH1A1 (0.53) ALDH1A1MEN1KMT2AGAAPOLB
SCHEMBL6723447 0.82 KMT2A (0.50) ALDH1A1MEN1KMT2ATP53GAA
SCHEMBL6717793 0.82 KMT2A (0.50) ALDH1A1MEN1KMT2ATP53GAA
SCHEMBL6715762 0.82 BRD4 (0.54) ALDH1A1MEN1KMT2AHSD17B10POLB
SCHEMBL6717632 0.81 ATM (0.47) ALDH1A1MEN1KMT2AGAAPOLB
SCHEMBL21987995 0.80 KLK7 (0.44) ALDH1A1MEN1KMT2AGAAPOLB
SCHEMBL6713979 0.80 ALDH1A1 (0.53) ALDH1A1MEN1KMT2AGAAPOLB
SCHEMBL6715563 0.80 CRHBP (0.54) ALDH1A1TP53GAAEGFRPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040152740-A1 Arylglycine derivatives for use as glycine transport inhibitors NPS ALLELIX CORPORATION (CA) 2004-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040152740-A1 Arylglycine derivatives for use as glycine transport inhibitors SLC1A2, SLC6A7, SLC1A1 ALDH1A1 572/4885MEN1 2933/4885KMT2A 2020/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.